Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 3/2010

01-03-2010

Evidence-based Guidelines for Perioperative Management of Diabetes in Cardiac and Vascular Surgery

Authors: Jennifer Wong, Sophia Zoungas, Chris Wright, Helena Teede

Published in: World Journal of Surgery | Issue 3/2010

Login to get access

Abstract

Background

Management of patients with hyperglycaemia undergoing vascular and cardiac surgery is important, with mounting evidence that hyperglycaemia in this setting is associated with worse outcomes. Evidence-based guidelines for the management of these patients have been limited.

Methods/Results

Our institution was aware of the lack of standardization of care in this growing population group and formed a multidisciplinary guideline development group to develop evidence-based guidelines to standardize the perioperative management of hyperglycaemia.

Conclusion

This series of articles outlines the process of developing evidence-based guidelines and the recommendations for perioperative management of patients with hyperglycaemia and diabetes undergoing cardiac and vascular surgery at our institution.
Literature
1.
2.
Dunstan DW, Zimmet PZ, Welborn T, on behalf of the AusDiab Steering Committee et al (2001) Diabesity and associated disorders in Australia-2000. The accelerating epidemic. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab). International Diabetes Institute, Melbourne
3.
Latham R, Lancaster A, Covington J et al (2001) The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22(10):607–612CrossRefPubMed
4.
Lauruchskat AH (2005) Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing CABG. Circulation 112(16):2397–2402CrossRef
5.
Swenne CL, Lindholm C, Borowiec J et al (2005) Peri-operative glucose control and development of surgical wound infections in patients undergoing coronary artery bypass graft. J Hosp Infect 61:201–212CrossRefPubMed
6.
Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829–834CrossRefPubMed
7.
Consortium DAGD (2005) National evidence based guidelines for the management of type 2 diabetes, 2nd edn. National Health and Medical Research Council, Canberra
8.
(1998) Standards of medical care for patients with diabetes mellitus. Diabetes Care 21(Suppl 1):23S–31S
9.
10.
Uusitupa MI, Niskanen LK, Sitonen O et al (1993) Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36(11):1175–1184CrossRefPubMed
11.
Hypertension in Diabetes Study Group (1995) Prevalence of hypertension in newly presenting Type 2 diabetic patients and the association of risk factors for cardiovascular and diabetic complications. J Hypertension 11:309–317
12.
Kadoi Y, Saito S, Fujita N et al (2005) Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg 129(3):576–583CrossRefPubMed
13.
NBPA Committee (2004) Hypertension Management Guide for Doctors, 2004 Guideline. Heart Foundation, Sydney
14.
Guvener M, Pasaoglu I, Demircin M et al (2002) Perioperative hyperglycaemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 49(5):531–537CrossRefPubMed
15.
Trick WE, Scheckler WE, Tokars JI et al (2000) Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 119(1):108–114CrossRefPubMed
16.
Cohen O, Dankner R, Chetrit A et al (2003) Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG). Cardiovasc Surg 11(3):195–200CrossRefPubMed
17.
Salpeter SR, Greyber E, Pasternak GA et al. (2006) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Library, CD002967
18.
DAGD Consortium (2009) National evidence based guidelines for blood glucose control in type 2 diabetes. National Health and Medical Research Council, Canberra
19.
Gandhi GY, Nuttall GA, Abel MD et al (2007) Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med 146:233–243PubMed
20.
Ouattara A, Lecomte P, Le Manach Y et al (2005) Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103(4):687–694CrossRefPubMed
21.
Gandhi GY, Nuttall GA, Abel MD et al (2005) Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 80(7):862–866CrossRefPubMed
22.
Whipple AO, Frank VO (1937) Adenoma of islet cell tumours with hyperinsulinism. Am J Pathol 14:125–138
23.
Vriesendorp TM, DeVries JH, Holleman F et al (2005) The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther 7(2):315–322CrossRefPubMed
24.
Lazar HL, Chipkin SR, Fitzgerald CA et al (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events [see comment]. Circulation 109(12):1497–1502CrossRefPubMed
25.
Gavin LA (1989) Management of diabetes mellitus during surgery. West J Med 151:1525–1529
26.
Rady MY, Johnson DJ, Patel BM et al (2005) Influence of individual characteristics on outcome of glycaemic control in intensive care unit patients with and without diabetes mellitus. Mayo Clin Proc 80(12):1558–1567CrossRefPubMed
27.
Whitcomb BW, Pradhan EK, Pittas AG et al (2005) Impact of admission hyperglycaemia on hospital mortality in various intensive care unit populations. Crit Care Med 33(12):2772–2777CrossRefPubMed
28.
Freire AX, Bridges L, Umpierrez GE et al (2005) Admission hyperglycaemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 128(5):3109–3116CrossRefPubMed
29.
Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients: a prospective study. Intensive Care Med 30:1685–1688CrossRefPubMed
30.
Zerr KJ, Furnary AP, Grunkemeier GL et al (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356–361CrossRefPubMed
31.
Carr JM, Sellke FW, Fey M et al (2005) Implementing tight glucose control after coronary bypass surgery. Ann Thorac Surg 80:902–909CrossRefPubMed
32.
Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367CrossRefPubMed
33.
Furnary A, Wu Y, Bookin SO (2004) Effect of hyperglycaemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10(2):21–33PubMed
34.
NICE-SUGAR Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297CrossRef
35.
Gore MO, McGuire DK (2009) The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab Vasc Dis Res 6(1):53–55CrossRefPubMed
36.
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).[see comment]. Lancet 352(9131):837-853 [erratum: Lancet 1999 Aug 14;354(9178):602]
37.
Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24):2457–2471CrossRefPubMed
38.
Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167CrossRefPubMed
Metadata
Title
Evidence-based Guidelines for Perioperative Management of Diabetes in Cardiac and Vascular Surgery
Authors
Jennifer Wong
Sophia Zoungas
Chris Wright
Helena Teede
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 3/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0380-0

Other articles of this Issue 3/2010

World Journal of Surgery 3/2010 Go to the issue

OriginalPaper

Significance of Lavage Cytology in Advanced Gastric Cancer Patients

OriginalPaper

Training Higher Surgical Trainees in Laparoscopic Common Bile Duct Exploration

ReviewPaper

Surgeons Without Borders: A Brief History of Surgery at Médecins Sans Frontières

OriginalPaper

An Algorithm Informed by the Parathyroid Hormone Level Reduces Hypocalcemic Complications of Thyroidectomy

OriginalPaper

Complications Analysis with Postoperative Choledochoscopy for Residual Bile Duct Stones

OriginalPaper

Standard Outpatient Re-Evaluation for Patients Not Admitted to the Hospital After Emergency Department Evaluation for Acute Abdominal Pain